Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events
To access the conference call:
U.S. callers should dial +1-877-407-0989 and international callers should dial +1-201-389-0921 approximately five minutes before the call begins.- Participants should ask to be connected to the Editas Medicine Earnings Conference Call.
The conference call will also be webcast and can be accessed from the “Investors” section of the
In addition to the conference call, management will participate in the following upcoming investor conferences:
TD Cowen 44th AnnualHealth Care Conference
Format: Fireside Chat
Date:Monday, March 4
Time:12:50 p.m. ET
Location:Boston, MA
Leerink Partners Global Biopharma Conference
Format: Fireside Chat
Date:Tuesday, March 12
Time:10:40 a.m. ET
Location:Miami Beach, FL
- Barclays 26th Annual Global Healthcare Conference
Format: Fireside Chat
Date:Wednesday, March 13
Time:2:05 p.m. ET
Location:Miami Beach, FL
To access the live webcasts of Editas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.
About
As a clinical-stage genome editing company,
![](https://ml.globenewswire.com/media/NTJkMTMxNDUtZTI4NC00OWI2LTk2ZWUtNGEwOWZjYmQ2MzI5LTEwMzc1OTk=/tiny/Editas-Medicine-Inc-.png)
Media and Investor Contact:Cristi Barnett (617) 401-0113 cristi.barnett@editasmed.com
Source: Editas Medicine, Inc.